Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KRAS encodes a small membrane-associated protein acting as a central node for transmitting growth factor signals from outside the cell into key intracellular signaling cascades controlling proliferation. Its function depends on regulated cycling between inactive GDP-bound and active-GTP bound states—a process disrupted by oncogenic mutations that drive many human cancers through persistent activation of mitogenic/survival pathways.
Inhibition of KRAS G12C mutant
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kirsten rat sarcoma viral oncogene homolog (KRAS).